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Abstract
Reactive oxygen species (ROS) have been implicated as one of the agents responsible for many
neurodegenerative diseases. A critical target for ROS is DNA. Most oxidative stress-induced DNA
damage in the nucleus and mitochondria is removed by the base excision repair pathway. Apn1 is a
yeast enzyme in this pathway which possesses a wider substrate specificity and greater enzyme
activity than its mammalian counterpart for removing DNA damage, making it a good therapeutic
candidate. For this study we targeted Apn1 to mitochondria in a neuronal cell line derived from the
substantia nigra by using a mitochondrial targeting signal (MTS) in an effort to hasten the removal
of DNA damage and thereby protect these cells. We found that following oxidative stress,
mitochondrial DNA (mtDNA) was repaired more efficiently in cells containing Apn1 with the MTS
than controls. There was no difference in nuclear repair. However, cells that expressed Apn1 without
the MTS showed enhanced repair of both nuclear and mtDNA. Both Apn1-expressing cells were
more resistant to cell death following oxidative stress compared with controls. Therefore, these
results reveal that the expression of Apn1 in neurons may be of potential therapeutic benefit for
treating patients with specific neurodegenerative diseases.
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The level of reactive oxygen species (ROS), a byproduct of oxidative phosphorylation, has
been found to be elevated in cells from postmortem specimens taken from patients with chronic
neurodegenerative diseases (Jenner 2003; Wu et al. 2003). ROS can pose a threat to cellular
homeostasis, function and lifespan by oxidizing lipids (Gutteridge and Halliwell 1990),
proteins (Starke-Reed and Oliver 1989), and nucleic acids (Dizdaroglu 1992). With respect to
nucleic acids the amount of DNA adducts has been found to be increased (Jenner 2003), which
suggests that ROS-induced DNA damage may be at least in part responsible for
neurodegeneration. Of the DNA found in the cell, it has been reported that mitochondrial DNA
(mtDNA) is more sensitive to oxidative stress than nuclear DNA (nDNA) (Yakes and Van
Houten 1997), likely because of its close proximity to the production of ROS. Although some
investigators have disputed this increased sensitivity (Lim et al. 2005), it is clear that there are
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various consequences which can result from the failure to protect mtDNA against ROS
exposure or repair the resulting damage. These include the induction of mutations, altered gene
expression and, eventually, cytostasis, cytotoxicity, or neoplastic growth (Wallace 1994,
2005; Evans and Cooke 2004). Thus, it is readily apparent that damage to mtDNA could have
significant functional consequences. Therefore, it is essential that damage in both nuclear and
mitochondrial DNA be repaired efficiently.
The short patch base excision repair (BER) pathway is required for repair of single-base
modifications in DNA caused by ROS or spontaneous depurinations in both the nucleus and
the mitochondrion. This BER pathway involves four basic enzymatic steps, with the flow of
each step to the next having been described as the handing over of a baton (Wilson and Kunkel
2000), such that the intermediate products, which may often be mutagenic, are passed from
one enzyme to the next. The first step is the recognition and removal of the damaged nucleotide
by a glycosylase, resulting in the generation of an abasic site (AP site). The predominant group
of glycosylases which specifically recognize oxidatively damaged bases is the bifunctional
glycosylases (Hazra et al. 2003). With these glycosylases, the intrinsic class I AP endonuclease,
known as AP lyase, performs the second step of cleaving the DNA sugar phosphate backbone
3′ to the AP site, generating either a 3′-blocking end, such as a 3′-α, β-unsaturated aldehyde
via β-elimination or a 3′- phosphate via β, δ-elimination. These 3′-blocked terminals are
subsequently removed by the 3′-phosphodiesterase activity associated with class II AP
endonucleases, generating a 3′-hydroxyl group. Alternatively, spontaneously generated or
monofunctional glycosylase produced AP sites can be cleaved by class II AP endonucleases
5′ to the AP site, generating a 5′-deoxyribose phosphate which requires a 5′-deoxyribose
phosphatase (5′-dRPase) activity for its removal to form a 5′-phosphate. The third step in BER
is the nucleotide synthesis step and is performed by either DNA polymerase β in the nucleus
or polymerase γ in mitochondria. The final step is the ligation of the DNA strands which is
accomplished by a DNA ligase. The particular sub-pathway for repair is determined by the
type of DNA glycosylase utilized for the removal of the modified base (Fortini et al. 1999).
Apn1, a homologue of E. coli Endonuclease IV, is the major class II AP endonuclease in
Saccharomyces cerevisiae. This 1104 bp gene has a bi-partite nuclear localization signal (NLS)
which targets Apn1 to the nucleus (Ramotar et al. 1993). Although the Apn1 gene does not
have a mitochondrial targeting signal (MTS), the Apn1 protein is sent to mitochondria in yeast
through its association with the Pir1 protein (Vongsamphanh et al. 2001). In addition to its
class II AP endonuclease and 3′-phosphodiesterase activities, Apn1 also participates in
nucleotide incision repair (Ischenko and Saparbaev 2002), which is a glycosylase independent
repair mechanism for repairing DNA damage generated by ionizing radiation, such as α-2′-
deoxynucleosides, 5,6-dihydro-2′-deoxyuridine, 5,6-dihydrothymidine, and 5-hydroxy-2′-
deoxyuridine (Gros et al. 2004), without producing mutagenic AP sites.
As mentioned above, oxidative stress-induced DNA damage is often recognized and cleaved
by bi-functional glycosylases, generating an intermediate product that contains 3′-blocking
groups, which require enzymes with 3′-phosphodiesterase activity for their removal. Kinetic
studies have revealed that the 3′-phosphodiesterase activity of Apn1 is more robust than that
of its human counterpart, AP endonuclease APE1 (Johnson and Demple 1988; Suh et al.
1997), which is the main enzyme responsible for this activity in humans (Parsons et al.
2004). In addition, Apn1 is active whereas APE1 is insufficient for removing 3′-phosphate
groups (Wiederhold et al. 2004), which must be removed by polynucleotide kinase (PNK) in
the nucleus (Wiederhold et al. 2004). Also, others have reported that Apn1 is more effective
than APE1 at enhancing cell survival (Wilson et al. 1995; Tomicic et al. 1997). Therefore,
Apn1 has been the subject of interest for developing therapeutic tools against
neurodegenerative diseases that may be caused by heightened oxidative stress (Mol et al.
2000).
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Despite the higher enzyme efficiency (Frosina 2001) and wider substrate specificity (Ischenko
and Saparbaev 2002; Ishchenko et al. 2004) of Apn1 compared with APE1, and the higher
mutation rate observed in mtDNA than nDNA following oxidative stress, there has been only
a few reports of attempted expression of Apn1 in mammalian cells (Tomicic et al. 1997; He
et al. 2001; Roth et al. 2003), and none has addressed the question as to whether targeting
Apn1 to mitochondria in mammalian cells could further enhance DNA repair and cell survival.
Herein we report the first study, to our knowledge, to target Apn1 to mitochondria in
mammalian cells. RCSN-3 cells transfected with HA-tagged Apn1, either with, or without an
MTS and enhanced mtDNA repair and improved cell survival were observed following
oxidative stress. The results of this study suggest that some neurodegenerative processes can
be attenuated by targeting Apn1 to either the nucleus or mitochondria.
Materials and methods
Materials
Dulbecco's modified Eagle medium (DMEM), Hanks’ Balanced Salt Solution (HBSS),
RadPrime DNA Labeling System Geneticin (G418) were from Invitrogen (Grand Island, NY,
USA). Fetal bovine serum was purchased from Hyclone (Logan, UT, USA). Gentamycin
sulfate, menadione bisulfate, a derivative of menadione (Morrison et al. 1984; Frei et al.
1986), hematoxylin, and NP-40 were from Sigma (St Louis, MO, USA). FuGENE 6
Transfection Reagent, restriction endonucleases, and Rnase A were from Roche Molecular
Biochemicals (Indianapolis, IN, USA). PolyFect Transfection Reagent was from Qiagen
(Valencia, CA, USA). Oligonucleotides, purified E. coli Fpg, human APE, and Comet Assay
kit were from Trevigen (Gaithersburg, MD, USA). T4 polynucleotide kinase (PNK) was from
Promega (Madison, WI, USA). Chemiluminescent reagents were from SuperSignal, Pierce
(Rockford, IL, USA). Zeta-Probe GT nylon membranes were from Bio-Rad (Hercules, CA,
USA). Antibodies were obtained from the following sources: the antibody against Apn1 was
a generous gift from Dr. D. Ramotar (University of Montreal, Montreal, Quebec, Canada); the
antibody against flavoprotein (complex II in mitochondria) was from Molecular Probe
(Eugene, OR, USA), anti-cytochrome c from BD PharMingen (San Diego, CA, USA); anti-
proliferating cell nuclear antigen (PCNA), anti-tyrosine hydroxylase and horseradish
peroxidase-conjugated anti-mouse or anti-rabbit IgG antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA); anti-HA antibody was from Sigma.
Plasmid constructs
To obtain a plasmid with the Apn1 gene connected to the MTS from the human MnSOD gene
(Dobson et al. 2000) and hemagglutinin (HA) 5′ to Apn1 (MTS/HA/APN1), a BamHI/XbaI
fragment containing the Apn1 gene was cloned into the BamHI/XbaI site of pcDNA3.neo
plasmid containing an elongation factor 1 alpha promoter (EF1a) and a MTS/HA sequence.
To generate HA/APN1 plasmid, the same BamHI/XbaI fragment containing the Apn1 gene
was cloned into the BamHI/XbaI site of pcDNA3.neo plasmid containing an EF1a/HA
sequence. The constructs obtained were sequenced to verify the integrity of the reading frame
and the fidelity of the sequence.
Cell culture and transfection
Raul Caviedes Substantia Nigra (RCSN-3) cells, a neuronal cell line derived from 4-month-
old normal Fischer 344 rat substantia nigra pars compacta (Paris et al. 2001), were cultured in
DMEM/HAM-F12 (1 : 1), supplemented with 10% fetal bovine serum and 40 mg/L gentamycin
sulfate, and incubated in 5% CO2 at 37°C in a humidifier chamber. The MTS/HA/Apn1 and
HA/Apn1 plasmids were transfected into RCSN-3 cells using FuGENE 6 Transfection Reagent
or PolyFect Transfection Reagent, respectively, following the manufacturer's
recommendations. As a negative control, cells were transfected with the pcDNA3.neo vector
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alone using FuGENE. Colonies of transfected RCSN-3 cells were selected with 0.6 mg/mL
G418 and clones were picked and maintained with 0.5 mg/mL G418 in normal growth media
thereafter. The insertion of the plasmids was verified by Southern blot analysis, and the
expression of the recombinant protein was verified by Western blot analysis.
Subcellular protein fractionation
Nuclear and mitochondrial extracts were isolated as previously described with some
modifications (Storrie and Madden 1990). Transfected RCSN-3 cells grown to confluence in
four 150 mm culture dishes were harvested using a rubber policeman and collected by
centrifugation. All procedures were conducted on ice or at 4°C. Cells were washed twice in 2
mL of divalent cation-free phosphate-buffered saline (PBS) (0.14 mol/L NaCl, 0.01 mol/L KCl
and 0.01 mol/L NaH2PO4) and homogenized in a PBS containing 0.25 mol/L sucrose by 15
strokes in a Dounce homogenizer (Kontes Glass Company, Vineland, NJ, USA). The lysate
was examined with a light microscope to ensure 90−95% cell lysis. The nuclear pellet was
collected by centrifugation at 1300 g for 10 min twice, and washed in nuclear wash solution
(0.25 mol/L sucrose, 10 mmol/L NaCl, 10 mmol/L Tris–HCl and 1.5 mmol/L MgCl2), vortexed
in detergent (one part 10% sodium deoxycholate and two parts NP-40) and collected by
centrifugation at 1300 g for 5 min.
The supernatants containing mitochondria were pooled and centrifuged first at 1300 g for 10
min to remove any nuclear contaminant, and then at 13 000 g for 20 min to pellet mitochondria.
The mitochondrial pellet was then air dried and resuspended in sucrose–Tris/EDTA buffer (50
mmol/L Tris pH 7.4, 5 mmol/L EDTA and 20% sucrose) and carefully loaded onto a 1.0 mol/
L/ 1.5 mol/L discontinuous sucrose gradient, of which the latter was frozen at −70°C the
previous night. The mitochondrial suspension was centrifuged at 50 000 g for 15 min in a
Beckman SW 50.1 rotor (Beckman Coulter, Fullerton, CA, USA). Mitochondrial pellets were
collected at the interphase, washed in mannitol–sucrose buffer (210 mmol/L mannitol, 70
mmol/L sucrose, 5 mmol/L EDTA, 5 mmol/L Tris pH 7.5), and centrifuged for 20 min at 13
000 g. The mitochondrial and nuclear pellets were dried and lysed with lysis buffer containing
protease inhibitors. Protein concentrations were determined using the Bio-Rad protein dye
micro-assay following the manufacturer's recommendations (Bradford method).
Drug treatment
The redox cycler menadione bisulfate (MEN), a derivative of menadione (Morrison et al.
1984; Frei et al. 1986), was dissolved in HBSS to a 10 mmol/L stock solution and then diluted
to appropriate concentration (100−900 μmmol/L). Exposure to menadione or HBSS alone was
limited to 1 h in 5% CO2 at 37°C for all studies. Cells were approximately 80−90% confluent,
unless otherwise stated. Cells were processed immediately or regular culture media was
replaced and cells were allowed various periods of time to repair.
Southern blot analysis
Cells were lysed in 10 mmol/L Tris–HCl (pH 8.0), 1 mmol/L EDTA, 0.5% SDS and 0.3 mg/
mL proteinase K, and incubated overnight at 37°C, followed by the addition of 0.25 volume
of 5 mol/L NaCl. High molecular weight DNA was extracted with equal volumes of
chloroform/isoamyl alcohol (24 : 1) three times, followed by precipitation with 11 mol/L
ammonium acetate and 100% ethanol. DNA was then resuspended in distilled H2O, treated
with Rnase A (final concentration, 1 mg/mL) for 2 h, and digested with restriction enzyme
overnight at 37°C. For insert confirmation, BamHI and XbaI were used for Apn1(+)MTS cells
and XhoI and XbaI for Apn1(−)MTS cells. BamHI was used to digest total DNA in mtDNA
repair studies. Digested samples were precipitated, resuspended in TE buffer (10 mmol/L Tris,
pH 8.0, 1 mmol/L EDTA), and quantified using calf thymus DNA as standards in a Hoefer
DyNA Quant 200 fluorometer (GE Healthcare, Piscataway, NJ, USA). Samples for mtDNA
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repair studies were heated for 15 min at 70°C and cooled to 22°C. NaOH was added to a final
concentration of 0.1 N, and incubated at 37°C for 20 min followed by the addition of alkaline
loading dye. Samples were loaded onto a horizontal 0.6% alkaline agarose gel for mtDNA
repair studies, 1% neutral gel for insert confirmation, and electrophoresed at 30 V (1.5 V/cm
gel length) for 16 h. After ethidium bromide staining to confirm even loading and standard gel
washes, the DNA was transferred to Zeta-Probe GT nylon membranes (Bio-Rad) and cross-
linked in a GS Gene Linker UV Chamber (Bio-Rad). To confirm Apn1 insertion, membranes
were hybridized with a 32P-labeled HA/Apn1 fragment generated by a RadPrime DNA
Labeling System, and the plasmids were used as a positive control. For mtDNA repair studies,
the membranes were hybridized with a 32P-labeled rat mtDNA-specific PCR-generated probe.
Hybridization and subsequent washes were performed according to the manufacturer's
recommendations. Mitochondrial DNA damage and repair were determined as previously
described (Driggers et al. 1993, 1997).
Western blot analysis
A total of 30 μg of protein from whole cell, nuclear, or mitochondrial fractions was denatured
and resolved by 12.5% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF)
membrane using standard procedures. The membrane was blocked in 5% non-fat dry milk/
Tris–buffered saline (TBS) overnight at 4°C, and immunoblotted with primary antibody in
0.05% Tween 20/2% non-fat dry milk/TBS (TBST) for 1 h. Following two 5 min washes in
TBST, the membrane was probed with a horseradish peroxidase-conjugated anti-mouse or anti-
rabbit IgG antibody for 30 min. After two more 5 min TBST washes, the immuno-complex
was detected using chemiluminescent reagents. The antibody against flavoprotein (complex II
in mitochondria) and cytochrome c were used to detect mitochondrial contaminant in nuclear
extracts, and anti-PCNA antibody was used to detect nuclear contaminant in mitochondrial
extracts.
Oligonucleotide cleavage assay
The AP endonuclease and 3′-phosphodiesterase activities of Apn1 were evaluated by an
oligonucleotide cleavage assay. In brief, a 21-mer oligonucleotide with an abasic site (AP) at
the 10th position was 5′-end labeled. The labeling reaction consisted of 20 pmol of the single
stranded oligonucleotide, 5 pmol of 33P-ATP, T4 polynucleotide kinase (PNK), and
appropriate kinase buffer in a total volume of 20 μL, incubated for 45 min at 37°C and 10 min
at 68°C. Complementary oligonucleotide was then added at 22°C to form duplex DNA.
Activity assays contained 0.5 pmol of labeled duplex oligonucleotide, 1X REC Buffer (100
mmol/L HEPES-KOH pH 7.4, 100 mmol/L KCl), 1 μg of protein extract in a 10 μL reaction
volume and were incubated with increasing time points at 37°C. The oligonucleotide used to
detect only the AP endonuclease activity, and not AP lyases in the extract contained a synthetic
AP site, a tetrahydrofuran (THF). The substrate for 3′-phosphodiesterase activity was generated
by digesting an AP oligonucleotide with E. coli Fpg, and 0.5 pmol of the resulting 5′-end labeled
3′-phosphate oligonucleotide was incubated with protein extracts as described above. Purified
human APE was used to produce positive controls for identifying the location of cleavage
products. Two microliters of the reaction products from assaying AP endonuclease activity
were resolved in 20% polyacrylamide gel with 7 mol/L urea, and from assaying 3′-
phosphodiesterase activity were resolved in 8% polyacrylamide sequencing gel with 7 mol/L
urea. Wet gels were autoradiographed at −70°C.
Single cell gel electrophoresis/Comet assay
Total DNA damage was assessed by single cell gel electrophoresis, or Comet assay using a
Comet Assay kit according to the manufacturer's protocol. In brief, transfected cells were
exposed to 0, 300, 600 or 900 μmol/L menadione. Cells that were collected by mechanical
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dislodging and centrifugation at 300 g for 5 min at 22°C were washed and resuspended in ice
cold PBS at a concentration of 1 × 105 cells/mL. Next, cells were added to low melting agarose
and spread into a thin layer on two different microscope slides. After solidification, cells were
lysed on ice for 45 min. Following incubation at 37°C for 30 min, slides were incubated in an
alkali solution (pH 12.1) for 30 min to unwind the double-stranded DNA followed by
neutralization in TBE buffer. Electrophoresis was conducted in TBE at 1 V/cm between the
two electrodes for 20 min. The slides were dipped in 100% cold ethanol for 5 min and air dried.
Finally, the DNA was stained with SYBR green and observed using fluorescent microscopy
with an Olympus BX-FLA System (Olympus, Center Valley, PA, USA) and photographed
using Magna Fire 2.1C software (Optronics, Goleta, CA, USA). The tail length, or the distance
of DNA migration, was defined as the distance between the leading edge of the nucleus and
the end of the tail. This is proportional to the level of single stranded breaks and abasic sites
in DNA. The data were analyzed from a minimum of 65 cells per cell type per dose using the
Fuji Image Gauge software (Fuji Film Life Science, Stamford, CT, USA). Data represent three
separate experiments.
Colony formation assay
Cell viability was determined by a colony formation assay. Due to a difference in cell attaching
efficiency, 500, 700, or 600 cells (vector only controls, Apn1(+)MTS, or Apn1(−)MTS cells,
respectively) were plated in 60-mm dishes and exposed to MEN at various concentrations for
1 h. Cells were allowed to proliferate in culture media for 10 days following drug treatment,
with fresh media replacement every 3 days. On the 10th day, the culture media was removed,
and cells were fixed in methanol : acetate (3 : 1) for 10 min and stained with hematoxylin for
10 min. Visible colonies were counted following several gentle washes with distilled H2O.
Results
Transfection of RCSN-3 cells with Apn1
To determine whether HA/Apn1 plasmids with or without the MTS were inserted correctly
into the RCSN-3 genome, qualitative Southern blot analyses were performed using total
genomic DNA from transfected RCSN-3 cells. Blots were hybridized using a 32P-labeled Apn1
fragment as the probe. For cells transfected with the MTS/HA/Apn1 containing plasmid [Apn1
(+)MTS], clone two of the three clones that showed full length insertion of the plasmid was
used for subsequent analyses (Fig. 1a). For cells transfected with the HA/Apn1 containing
plasmid [Apn1(−)MTS], clone four of the four clones identified to contain the full length insert
was used for subsequent analyses (Fig. 1b).
RCSN-3 cells retain the ability to express tyrosine hydroxylase
To ensure that the transfected RCSN-3 cells were still functional, whole cell lysates from the
transfected cells were immunoblotted against tyrosine hydroxylase, the rate-limiting enzyme
in the synthesis of dopamine using Western blot analysis. Lysates from HeLa cells were used
as a negative control. Fig. 1(c) shows that transfection did not alter the cells’ ability to express
tyrosine hydroxylase.
Recombinant Apn1 proteins are expressed
To verify that the recombinant Apn1 protein was targeted to either the nucleus or the
mitochondrion, pure subcellular fractions were immunoblotted for the presence of HA or Apn1
by Western blot analysis. To ensure that the fractions were free of contamination, they were
probed for the presence of flavoprotein, a subunit forming complex II of the electron transport
chain in the inner membrane of mitochondria; cytochrome c, a mitochondrial protein found in
the intermembrane space; and PCNA, a nuclear protein (Fig. 2a). Mitochondrial fractions from
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all three cell types (vector only, Apn1(+)MTS and Apn1(−)MTS) were free of nuclear
contaminants (Fig. 2a, lanes 1−3). The nuclear fractions of all three cell types were free of
mitochondrial contaminants (Fig. 2a, lanes 4−6).
Whole cell, mitochondrial, and nuclear fractions were obtained and the presence of the
recombinant Apn1 was verified by Western blot analysis using either HA or Apn1 antibodies
(Fig. 2b). As expected, Apn1 was not detectable in the whole cell, mitochondrial, or nuclear
fractions from vector only controls. In Apn1(−)MTS cells, Apn1 was present in whole cell
lysate and the nuclear fraction, and was absent in the mitochondrial extract. In Apn1(+)MTS
cells Apn1 was found in both mitochondrial and nuclear extracts, as well as the whole cell
lysates. The reason for this dual localization likely is that a portion of Apn1 expressed in Apn1
(+)MTS cells was imported to the nucleus by its inherent NLS.
Recombinant Apn1 proteins are active
Apn1 is a multi-functional protein (Popoff et al. 1990; Ischenko and Saparbaev 2002;
Ishchenko et al. 2003, 2004, 2005). To determine whether it was functionally active in cells,
the AP endonuclease and 3′-phosphodiesterase activities of Apn1 were assayed using an
oligonucleotide cleavage assay. To evaluate AP endonuclease activity, a synthetic 21-mer
oligonucleotide containing a THF modified AP-site at position 10 was 5′ end-labeled with
P33, annealed with its complementary oligonucleotide, and incubated with equal amounts of
either mitochondrial (Fig. 3a) or nuclear (Fig. 3b) extracts for increasing periods of time.
Enzymes with AP endonuclease activity cleave the 21-mer oligo-nucleotide 5′ to the THF-AP
site; the end product is a 9-mer fragment. In order to distinguish between the endogenous AP
endonuclease activity from that of the recombinant Apn1, 10 mmol/L EDTA was added to
both the lysis buffer and reaction buffer, which also contained 0.2 mmol/L ZnCl2, to inactivate
endogenous AP endonuclease activity. As shown in Fig. 3, pure APE using the manufacturer's
buffer (Fig. 3a lane 2) gave a product band at the 9-mer position, while pure APE with the
reaction buffer containing 10 mmol/L EDTA produced a band with much less intensity (Fig.
3b lane 1).
In the mitochondrial extract (Fig. 3a), there was not an increase in the intensity of product
bands at the 9-mer position in vector only controls (lanes 3−6) nor in the Apn1(−)MTS extracts
(lanes 11−14). However, AP endonuclease activity was apparent in extracts from Apn1(+)MTS
cells (lanes 7−10). Similarly, in the nuclear extracts (Fig. 3b), bands at the 9-mer position were
absent in vector only controls (Fig. 3b, lanes 3−6). However, in the nuclear extracts from both
Apn1 expressing cells, either with or without the MTS, the 9-mer product appeared in a time-
dependent manner (Fig. 3b, lanes 7−10 and 11−14, respectively).
The 3′-phosphodiesterase activity of Apn1 also was assayed using an oligonucleotide cleavage
method. To prepare the 3′-phosphate substrate for testing for 3′-phosphodiesterase activity, a
synthetic 21-mer oligonucleotide containing an AP site at the 10th position (Fig. 3c; lane 1)
was first 5′end-labeled with 33P and incubated with E. coli Fpg glycosylase (lanes 3 and 4).
The AP lyase activity associated with this glycosylase cleaves the sugar phosphate backbone
3′ to the AP site, generating a 3′-blocking group. The position of the substrate is shown in lanes
3 and 4, with the difference being that the substrate in lane 4 was prepared in bulk to provide
sufficient substrate for incubation with the cell extracts, while the substrate in lane 3 was
prepared with only 0.5 pmol of the AP oligonucleotide. The end product, a 3′-hydroxyl
containing 9-mer, generated by incubating purified human APE with the AP oligonucleotide
(lane 2), is a slower migrating product (Ishchenko et al. 2003;Jilani et al. 2003). Mitochondrial
and nuclear extracts from vector only controls showed no 3′-phosphodiesterase activity (lanes
5−7 and 14−16, respectively). However, strong 3′-phosphodiesterase activity was present in
both the mitochondrial and nuclear extracts from Apn1(+)MTS cells (lanes 8−10 and 17−19,
respectively). The mitochondrial extract from Apn1(−)MTS cells contained a barely detectable
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amount of 3′-phosphodiesterase activity (lanes 11−13), likely due to a minor undetected
contamination, while the nuclear extract, as expected, had a prominent 3′-phosphodiesterase
activity (lanes 20−22). Therefore, the results of the Apn1 activity assay show that the
recombinant Apn1 protein has active AP endonuclease and 3′-phosphodiesterase activities.
These results also support the Western blot results from Fig. 2(b) which showed that Apn1 was
present in both nuclei and mitochondria in Apn1(+)MTS cells.
Apn1 expressing RCSN-3 cells have more efficient mtDNA repair capacity
The 3′-phosphodiesterase activity associated with Apn1 is responsible for removing the 3′-
blocking group generated as a result of AP lyase activity from glycosylase/AP lyases which
recognize oxidized DNA. As reactive oxygen species generated by MEN are directed via
complex I of the electron transport chain to the matrix where mtDNA resides, we tested the
hypothesis that mtDNA repair would be more efficient in cells expressing Apn1 targeted to
mitochondria when compared with vector only controls and Apn1(−)MTS cells. The
transfected cells were exposed to MEN for 1 h to a dose which generated a break frequency
between 0.5 and one break per 10 kb restriction fragment of mtDNA. Subsequently, cells were
allowed to repair for either 2 or 6 h in regular culture media. A representative autoradiograph
of a quantitative alkaline Southern blot analysis evaluating mtDNA repair (Fig. 4a) and a graph
summarizing the effects of three independent experiments (Fig. 4b) are shown. At 2 h, there
was no significant difference in mtDNA repair between the three cell types. However, by 6 h,
Apn1(+)MTS cells had repaired 54.5 ± 10.2% of the lesions in mtDNA compared with vector
only controls which only had repaired 22.4 ± 3.3% of the lesion (p < 0.05). Apn1(−)MTS cells
also repaired mtDNA more efficiently than vector only controls after 6 h (55.1 ± 3.4%; p <
0.05). There was no statistical difference in the efficiency of mtDNA repair between the two
Apn1 expressing cells.
Nuclear DNA damage was less extensive in RCSN-3 cells expressing Apn1 without the MTS
Although MEN generates ROS primarily in mitochondria, damage also has been observed in
nDNA from both human and rat cell lines exposed to this agent (Morrison et al. 1984; Martins
and Meneghini 1990; Ngo et al. 1991). Therefore, we examined the extent of nDNA damage
to see whether Apn1(+)MTS cells were able to reduce the amount of DNA damage following
MEN treatment. Single cell gel electrophoresis, also known as the Comet assay, was used to
analyze the extent of nDNA damage. In this technique, abasic sites and single strand breaks in
DNA can be detected when the lysed cells undergo alkaline treatment followed by neutral gel
electrophoresis. Figs 5 (a–f) show the results of the Comet assay when cells were treated to
600 μmol/L of MEN. Figs 5(a, c, and e) are the images obtained from fluorescent microscopy
when DNA was stained with SYBR green. Figs 5(b, d, and f) are the corresponding images
obtained from the software used to analyze the DNA. The distance of DNA migration
(sometimes referred to as tail length), which is proportional to the level of single strand breaks
and abasic sites in DNA (Tice et al. 2000), was measured by Image Gauge software. There
were significantly fewer single strand breaks and abasic sites in Apn1(−)MTS cells at 300,
600, and 900 μmol/L MEN than either vector only controls or Apn1(+)MTS cells (Fig. 5g).
There was no difference in the extent of nDNA damage between vector only controls and Apn1
(+)MTS cells (Fig. 5g).
Apn1 expression enhances cell survival
To determine whether mitochondrial targeting of Apn1 can reduce the cytotoxic effect of MEN,
cell viability was assessed by a colony formation assay (Fig. 6). Both Apn1 expressing cells
formed significantly more clones relative to cells containing only the vector following exposure
to all the doses of MEN examined (Fig. 6). There was no difference in survival between either
Apn1-expressing cells. Therefore, cell survival was enhanced in Apn1 expressing RCSN-3
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cells following oxidative stress, regardless of whether Apn1 was expressed with or without the
MTS.
Discussion
Many neurodegenerative diseases are associated with mutations in mtDNA (Wallace et al.
1998) suggesting a role for mtDNA damage in the pathogenesis of these diseases. In support
of this notion it has been recently demonstrated that there are high levels of mtDNA deletions
present in substantia nigra of older adults and patients with Parkinson's disease (Bender et al.
2006). Thus, it appears likely that damage to this DNA caused by oxidative stress which
produces subsequent mutations could play a significant role in the pathogenesis of these
diseases. Therefore, we sought to determine whether targeting the yeast AP/endonuclease Apn1
to mitochondria in a cell line derived from rat substantia nigra, would render them more
resistant to oxidative stress. The results showed that the two Apn1 constructs, one with, and
one without an MTS from human MnSOD, could be successfully transfected into RCSN-3
cells. The transfection process did not alter the dopaminergic properties of these cells, as
evidenced by their ability to express tyrosine hydroxylase. Apn1 was found to be present and
active in the nuclear fraction of Apn1(−)MTS cells whereas Apn1(+)MTS cells expressed
active Apn1 in both the nuclear and mitochondrial fractions. The localization to the nucleus
was likely due to the NLS inherent in the Apn1 gene. For future studies, truncating the NLS
may help target Apn1 exclusively to mitochondria. However, it has been reported that even
when the NLS was truncated from the Apn1 gene, there was still sufficient Apn1 entering into
the nucleus, possibly via passive diffusion, to increase resistance to DNA damaging agents in
yeast (Ramotar et al. 1993). Thus it appears likely that some nuclear localization cannot be
avoided.
Analysis of mtDNA repair following transfection revealed that it was enhanced following MEN
treatment in Apn1(+)MTS cells compared with vector only controls. However, surprisingly,
mtDNA repair also was enhanced in Apn1(−)MTS cells compared with vector only controls.
As Apn1 was found in the nuclear fraction of Apn1(+)MTS cells, the extent of nDNA damage
also was examined following MEN treatment. The presence of this enzyme in the nucleus did
not lead to enhanced protection of the DNA in this organelle. Cell viability studies revealed
that Apn1 expression in RCSN-3 cells, with or without the MTS, enhanced cell survival and
proliferation following oxidative stress.
To explain these results, we propose the following model (Fig. 7). We postulate that oxidative
damage to mtDNA and the resulting mutations cause defective electron transport by
impairment of the mitochondrially encoded components of these chains. This defective
electron transport results in heightened production of ROS, which further damage mtDNA and
cause more mutations and thus initiates a vicious cycle of escalating mtDNA damage and ROS
production. In support of this concept it has been shown that accumulation of mtDNA mutations
increased ROS production in many cell types (de Grey 2005;Petros et al. 2005;Simmons et
al. 2005). When mtDNA damage surpasses a specific threshold, it will act as the initiator of a
stress signal from mitochondria, likely through the generation of ROS, which some researchers
have referred to as the ‘retrograde signal’ (Mandavilli et al. 2002). This signal activates specific
transcription factors and/or signal transduction pathways, which in turn activate and/or enhance
DNA repair mechanisms in both the nucleus and mitochondria. This altered repair ultimately
leads to enhanced cell survival. In order for these events to occur, the integrity of the genes
which encode for all the factors involved must be intact. In support of this model, there is
evidence implicating mitochondria as the source of the signal which activates transcription
factors such as NFκB (Garcia-Ruiz et al. 1995;Hughes et al. 2005), and c-jun, AP-1, cAMP-
response element binding protein (CREB), and nuclear respiratory factor 1 (Storz et al.
2005), as well as other signal transduction cascades, such as protein kinase D (Storz et al.
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2005) and p38 MAPK (Emerling et al. 2005) through the generation of ROS. Furthermore, it
has been reported that DNA repair can be modulated by phosphorylation (Gu and Lu
2001;Parker et al. 2003;Hu et al. 2005). Therefore, this and other post-translational
modifications, activated by the mitochondrial signal, play a key role in regulating DNA repair
enzyme activity, localization and stability (Hu et al. 2005) and thereby influence cellular
resistance to oxidative stress.
To apply this model to the current study, we found that Apn1, which was stably expressed in
Apn1(−)MTS cells, enhanced nuclear DNA repair. We hypothesize that this enhanced nuclear
repair caused better preservation of nuclear genes which encode transcription factors, signal
transduction pathways and DNA repair enzymes. Following MEN treatment, which caused
oxidative damage to mtDNA, the retrograde signal was activated. This induced post-
translational modification of DNA repair enzymes which led to their translocation and/or
activation in both the nucleus and mitochondria. Due to the enhanced repair of mtDNA, the
escalating vicious cycle of ROS production and mtDNA damage was aborted and overall cell
survival was enhanced. In the case of vector only controls, although the retrograde signal had
been activated due to mtDNA damage, the endogenous DNA repair enzymes and factors
responsible for post-translational modifying these enzymes were insufficient to overcome the
damage to the DNA, and therefore cell survival was not enhanced. In the case of the Apn1(+)
MTS cells, the Apn1 present in mitochondria was directly responsible for enhancing mtDNA
repair, thus blocking the initiation of the vicious cycle and enhancing cell survival. Although,
Apn1 translocated to the nucleus, no enhanced protection of nDNA integrity was observed.
We believe that this is because this enzyme was unable to participate in BER. The current
concept of BER is that one enzyme hands over to the next enzyme in this process (Wilson and
Kunkel 2000). Because Apn1(+)MTS has an MTS, this peptide prevents the Apn1 in the
nucleus from handing over to the next enzyme (polymerase) in BER and repair is unable to
proceed. Mitochondria often clip off the MTS after proteins are translocated into them.
However, Western blot analysis revealed that this is not the case for the Apn1(+)MTS protein
as the bands from the nuclear and mitochondrial fractions were the same size (data not shown).
This surprising finding indicates that repair in mitochondria, likely due to the genome being
much simpler, is not as complex as in the nucleus and handing off from one step in repair to
the next is not necessary. We feel that the protective mechanism initiated by Apn1(+)MTS is
superior to that of Apn1(−)MTS because it blocks the initiation of the vicious cycle rather than
modulates the response to it.
In summary, to our knowledge, this is the first report of the expression Apn1 in mammalian
cells derived from the substantia nigra. We have found enhanced DNA repair in a mammalian
neuronal cell line expressing Apn1 with and without MTS. More importantly, this enhanced
repair led to increased cell survival in neurons, whether Apn1 was directly targeted to the
mitochondria or not. This indicates that Apn1 could be used as a possible treatment strategy
for attenuating or slowing down the pathogenesis of neurodegenerative diseases. Future work
in this laboratory will explore how protein transduction technology can be used to deliver this
protein therapeutically.
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Fig. 1.
Apn1 transfection in RCSN-3 cells and their dopaminergic property. (a and b) Southern blot
analyses showing that the HA-tagged Apn1 plasmids were incorporated into the RCSN-3
genome. (a) DNA from three clones containing the Apn1 plasmid with a mitochondrial
targeting sequence from the human MnSOD gene. (b) DNA from four clones containing the
Apn1 plasmid without the mitochondrial targeting sequence. Total DNA was isolated and
hybridized with the Apn1(+)MTS plasmid serving as the probe. Due to the different sites of
restriction enzyme cleavage, the probe hybridized to a fragment of a larger size in Apn1(−)
MTS clones. (c) A Western blot showing the expression of tyrosine hydroxylase in whole cell
lysates of cells transfected with vector only controls, Apn1(+)MTS or Apn1(−) MTS cells.
Lysates from HeLa cells were used as a negative control. Actin was used as a loading control.
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Fig. 2.
Expression of Apn1 in subcellular and whole cell extracts. (a) Pure subcellular fractions.
Purified mitochondrial (lanes 1−3) and nuclear (lanes 4−6) fractions from vector only control
(lanes 1 and 4), Apn1(+)MTS (lanes 2 and 5), and Apn1(−)MTS (lanes 3 and 6) cells were
immunoblotted against flavoprotein from complex II of the inner membrane of mitochondria,
PCNA, a nuclear protein, or cytochrome c, which resides in the inter-membrane space of
mitochondria. (b) Western blots showing Apn1 expression in purified nuclear, mitochondrial
extracts, and whole cell lysates from vector only controls, Apn1(+)MTS or Apn1(−)MTS cells.
The extracts were probed with anti-Apn1 antibody in nuclear extract and anti-HA antibody in
mitochondrial and whole cell lysates. The expected size of Apn1 is 40.5 kDa.
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Fig. 3.
AP endonuclease and 3′-phosphodiesterase activity assays. Mitochondrial (a) and nuclear (b)
extracts from vector only controls, Apn1(+)MTS, or Apn1(−)MTS cells were assayed for AP
endonuclease activity. Extracts were incubated with 5′-end labeled oligonucleotide containing
a modified AP site (THF lanes : lane 1 in panel a and lane 2 in panel b at 37°C for up to 30
min. Enzymes with AP endonuclease activity cleave the substrate 5′ to the AP site and the
product appears as a 9-mer. The substrates for lane 2 of panel a and lane 1 of panel b were
incubated with pure APE enzyme. The reaction buffer supplied by the manufacturer was used
in lanes 1 and 2 of both panel a and lane 2 of panel b. Modified reaction buffer containing 10
mmol/L EDTA and 0.2 mmol/L ZnCl2 was used in the remaining lanes. (c) 3′-
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Phosphodiesterase activity assays. A 5′-end labeled oligonucleotide containing an AP site (lane
1) was pre-cleaved by FPG (lanes 3 and 4) to generate the 3′-phosphate substrate for 3′-
phosphodiesterases. Mitochondrial (lanes 5−13) and nuclear (lanes 14−22) extracts from vector
only controls (lanes 5−7 and 14−16), Apn1(+)MTS (lanes 8−10 and 17−19), or Apn1(−)MTS
(lanes 11−13 and 20−22) cells were incubated with this substrate (lane 4) for 5, 15, or 30 min.
The position of the hydrolyzed 3′-phosphate, 3′-hydroxyl, is identical to the product formed
when pure APE cleaves the AP oligonucleotide (lane 2).
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Fig. 4.
Apn1 expression enhances mtDNA repair efficiency. Mitochondrial DNA integrity was
investigated in transfected RCSN-3 cells exposed to menadione following 2 or 6 h of repair.
An equal amount of total DNA was probed for mtDNA and the percent of repair calculated.
(a) Representative autoradiograph and (b) results of % repair (mean ± SE) from three
independent experiments. The percent repair of either Apn1(+)MTS or Apn1(−)MTS cells
differed significantly from vector only controls (*p < 0.05).
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Fig. 5.
Apn1 expression in the nuclei protects DNA from single strand breaks. Nuclear DNA damage
was assessed by single cell gel electrophoresis, or Comet assay, under alkaline treatment and
neutral gel electrophoretic conditions. Migration distance of the SYBR green stained DNA, or
tail length, which is proportional to the amount of DNA damage from vector only controls (a),
Apn1(+)MTS (c), or Apn1(−)MTS (e) cells exposed to 600 μmol/L menadione was measured
using analytical software (b,d and f). (g) Tail length (mean ± SE) from at least 65 cells was
measured per cell type, dose, and experiment. Results were obtained from three independent
experiments. *Indicates significant difference from vector only controls (p < 0.05).
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Fig. 6.
Apn1 expression enhances cell survival. Cell viability was determined by examining the
number of colonies formed 10 days following menadione exposure at various doses. *Indicates
significant difference from vector only controls (p < 0.05). Results were obtained from three
independent experiments.
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Fig. 7.
Model for observed phenomenon. Oxidative damage to mtDNA is required to activate a
retrograde signal from mitochondria which will ultimately lead to enhanced nDNA integrity,
mtDNA repair and cell survival, if the genes for the transcription factors, signal transduction
pathways and DNA repair enzymes involved were intact. This is demonstrated in Apn1(−)
MTS cells. If the genes were not intact, such as in the case of vector only controls, then no
mtDNA repair, nDNA integrity or cell survival enhancement would result. However, when
mtDNA repair was directly enhanced, such as in Apn1(+)MTS cells, cell survival also would
be enhanced, but nDNA integrity would not be enhanced because the retrograde signal was
not activated.
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